27237979|t|MiR-211 is epigenetically regulated by DNMT1 mediated methylation and inhibits EMT of melanoma cells by targeting RAB22A
27237979|a|MiR-211 has strong inhibitive effects on melanoma cell growth, invasion and metastasis. However, how it is downregulated and whether other genes are involved its downstream regulation in melanoma are not clear. In this study, we firstly verified the expression of miR-211 in melanoma cell lines and observed that its downregulation is associated with increased DNMT1 expression. By performing qRT-PCR and MSP analysis, we confirmed that DNMT1 is negatively correlated with miR-211 expression and can modulate DNA methylation in the promoter region of miR-211. By performing bioinformatics analysis, we found that RAB22A is a possible target of miR-211, which has two broadly conversed binding sites with miR-211 in the 3'UTR. Following dual luciferase assay, qRT-PCR and western blot analysis confirmed the direct binding between miR-211 and RAB22A and the suppressive effect of miR-211 on RAB22A expression. Knockdown of RAB22A increased epithelial properties and impaired mesenchymal properties of the melanoma cells, suggesting that miR-211 modulates epithelial mesenchymal transition (EMT) of melanoma cells via downregulating RAB22A. In summary, the present study firstly demonstrated that DNMT1 mediated promoter methylation is a mechanism of miRNA suppression in melanoma and revealed a new tumor suppressor role of the miR-211 by targeting RAB22A in melanoma. The DNMT1 / miR-211 / RAB22A axis provides a novel insight into the pathogenesis of melanoma, particularly in the EMT process.
27237979	0	7	MiR-211	T028	C1537847
27237979	11	35	epigenetically regulated	T043	C1160454
27237979	39	44	DNMT1	T028	C1414121
27237979	54	65	methylation	T044	C0025723
27237979	70	78	inhibits	T052	C3463820
27237979	79	82	EMT	T043	C1523298
27237979	86	100	melanoma cells	T025	C1513095
27237979	104	113	targeting	T063	C0242613
27237979	114	120	RAB22A	T028	C1419193
27237979	121	128	MiR-211	T028	C1537847
27237979	140	150	inhibitive	T052	C3463820
27237979	162	170	melanoma	T191	C0025202
27237979	171	182	cell growth	T043	C0007595
27237979	184	192	invasion	T046	C2699153
27237979	197	207	metastasis	T046	C4255448
27237979	228	241	downregulated	T044	C0013081
27237979	260	265	genes	T028	C0017337
27237979	283	293	downstream	T082	C0522506
27237979	294	304	regulation	T044	C0013081
27237979	308	316	melanoma	T191	C0025202
27237979	371	381	expression	T045	C0017262
27237979	385	392	miR-211	T028	C1537847
27237979	396	415	melanoma cell lines	T025	C1513095
27237979	438	452	downregulation	T044	C0013081
27237979	456	471	associated with	T080	C0332281
27237979	482	487	DNMT1	T028	C1414121
27237979	488	498	expression	T045	C0017262
27237979	514	521	qRT-PCR	T063	C1514628
27237979	526	538	MSP analysis	T062	C0026031
27237979	558	563	DNMT1	T028	C1414121
27237979	567	577	negatively	T033	C1513916
27237979	578	588	correlated	T080	C1707520
27237979	594	601	miR-211	T028	C1537847
27237979	602	612	expression	T045	C0017262
27237979	621	629	modulate	T082	C0443264
27237979	630	645	DNA methylation	T044	C0376452
27237979	653	668	promoter region	T114,T123	C0033413
27237979	672	679	miR-211	T028	C1537847
27237979	695	718	bioinformatics analysis	T091	C1140694
27237979	734	740	RAB22A	T028	C1419193
27237979	755	761	target	T169	C1521840
27237979	765	772	miR-211	T028	C1537847
27237979	796	805	conversed	T086	C0009802
27237979	806	819	binding sites	T192	C0005456
27237979	825	832	miR-211	T028	C1537847
27237979	840	845	3'UTR	T086,T123	C0600600
27237979	862	872	luciferase	T116,T126,T130	C0024075
27237979	873	878	assay	T059	C0005507
27237979	880	887	qRT-PCR	T063	C1514628
27237979	892	913	western blot analysis	T059	C0949466
27237979	935	942	binding	T044	C1167622
27237979	951	958	miR-211	T028	C1537847
27237979	963	969	RAB22A	T028	C1419193
27237979	978	996	suppressive effect	T045	C0038855
27237979	1000	1007	miR-211	T028	C1537847
27237979	1011	1017	RAB22A	T028	C1419193
27237979	1018	1028	expression	T045	C0017262
27237979	1030	1039	Knockdown	T063	C2350567
27237979	1043	1049	RAB22A	T028	C1419193
27237979	1060	1070	epithelial	T080	C0221908
27237979	1086	1094	impaired	T169	C0221099
27237979	1095	1106	mesenchymal	T080	C1513143
27237979	1125	1139	melanoma cells	T025	C1513095
27237979	1157	1164	miR-211	T028	C1537847
27237979	1165	1174	modulates	T082	C0443264
27237979	1175	1208	epithelial mesenchymal transition	T043	C1523298
27237979	1210	1213	EMT	T043	C1523298
27237979	1218	1232	melanoma cells	T025	C1513095
27237979	1237	1251	downregulating	T044	C0013081
27237979	1252	1258	RAB22A	T028	C1419193
27237979	1316	1321	DNMT1	T028	C1414121
27237979	1331	1339	promoter	T114,T123	C0033413
27237979	1340	1351	methylation	T044	C0025723
27237979	1357	1366	mechanism	T169	C0441712
27237979	1370	1375	miRNA	T114,T123	C1101610
27237979	1376	1387	suppression	T045	C0038855
27237979	1391	1399	melanoma	T191	C0025202
27237979	1419	1435	tumor suppressor	T028	C0079427
27237979	1448	1455	miR-211	T028	C1537847
27237979	1459	1468	targeting	T063	C0242613
27237979	1469	1475	RAB22A	T028	C1419193
27237979	1479	1487	melanoma	T191	C0025202
27237979	1493	1498	DNMT1	T028	C1414121
27237979	1501	1508	miR-211	T028	C1537847
27237979	1511	1517	RAB22A	T028	C1419193
27237979	1557	1569	pathogenesis	T046	C0699748
27237979	1573	1581	melanoma	T191	C0025202
27237979	1603	1614	EMT process	T043	C1523298